Eugia Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EUGIA PHARMA, and what generic alternatives to EUGIA PHARMA drugs are available?
EUGIA PHARMA has one hundred and sixty-eight approved drugs.
There is one US patent protecting EUGIA PHARMA drugs. There are three tentative approvals on EUGIA PHARMA drugs.
There are ten patent family members on EUGIA PHARMA drugs in nine countries and three hundred and thirty-seven supplementary protection certificates in eighteen countries.
Summary for Eugia Pharma
| International Patents: | 10 |
| US Patents: | 1 |
| Tradenames: | 142 |
| Ingredients: | 134 |
| NDAs: | 168 |
| Patent Litigation for Eugia Pharma: | See patent lawsuits for Eugia Pharma |
Drugs and US Patents for Eugia Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | FLUPHENAZINE DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 207739-001 | Oct 17, 2017 | AO | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eugia Pharma | NALOXONE HYDROCHLORIDE | naloxone hydrochloride | INJECTABLE;INJECTION | 212456-001 | Nov 4, 2019 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Eugia Pharma Speclts | PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 065498-003 | May 23, 2011 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Eugia Pharma Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 106456654 | ⤷ Try a Trial |
| Canada | 2948148 | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2015171460 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Eugia Pharma Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0454436 | 97C0012 | Belgium | ⤷ Try a Trial | PRODUCT NAME: OLANZAPINE; REGISTRATION NO/DATE: EU/1/96/022/001 19960927 |
| 1280520 | C300722 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720 |
| 1591122 | 132013902140458 | Italy | ⤷ Try a Trial | PRODUCT NAME: ACIDO ZOLEDRONICO(ACLASTA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/05/308/002, 20071003;57363, 20070927 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
